97 related articles for article (PubMed ID: 21641796)
1. Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors.
Storgaard M; Henriksen ST; Zaragoza F; Peschke B; Tanner D
Bioorg Med Chem Lett; 2011 Jul; 21(13):3918-22. PubMed ID: 21641796
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
[TBL] [Abstract][Full Text] [Related]
3. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
4. Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors.
Parlow JJ; Dice TA; Lachance RM; Girard TJ; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4043-9. PubMed ID: 12954057
[TBL] [Abstract][Full Text] [Related]
5. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
[TBL] [Abstract][Full Text] [Related]
6. Sugar amino acid based peptide epoxyketones as potential proteasome inhibitors.
Risseeuw MD; Florea BI; van der Marel GA; Overkleeft HS; Overhand M
Bioorg Chem; 2010 Oct; 38(5):202-9. PubMed ID: 20493511
[TBL] [Abstract][Full Text] [Related]
7. Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.
Kotian PL; Krishnan R; Rowland S; El-Kattan Y; Saini SK; Upshaw R; Bantia S; Arnold S; Babu YS; Chand P
Bioorg Med Chem; 2009 Jun; 17(11):3934-58. PubMed ID: 19409795
[TBL] [Abstract][Full Text] [Related]
8. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
[TBL] [Abstract][Full Text] [Related]
9. Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-Eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Jan; 326(4):859-65. PubMed ID: 15607748
[TBL] [Abstract][Full Text] [Related]
10. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
11. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
[TBL] [Abstract][Full Text] [Related]
13. Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I.
Josef KA; Kauer FW; Bihovsky R
Bioorg Med Chem Lett; 2001 Oct; 11(19):2615-7. PubMed ID: 11551762
[TBL] [Abstract][Full Text] [Related]
14. New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.
Becker GL; Hardes K; Steinmetzer T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4695-7. PubMed ID: 21757345
[TBL] [Abstract][Full Text] [Related]
15. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
[TBL] [Abstract][Full Text] [Related]
16. Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap.
Mete A; Andrews G; Bernstein M; Connolly S; Hartopp P; Jackson CG; Lewis R; Martin I; Murray D; Riley R; Robinson DH; Smith GM; Wells E; Withnall WJ
Bioorg Med Chem Lett; 2011 May; 21(10):3128-33. PubMed ID: 21450464
[TBL] [Abstract][Full Text] [Related]
17. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
Cregge RJ; Durham SL; Farr RA; Gallion SL; Hare CM; Hoffman RV; Janusz MJ; Kim HO; Koehl JR; Mehdi S; Metz WA; Peet NP; Pelton JT; Schreuder HA; Sunder S; Tardif C
J Med Chem; 1998 Jul; 41(14):2461-80. PubMed ID: 9651152
[TBL] [Abstract][Full Text] [Related]
20. CoMFA investigations on two series of artificial peptide inhibitors of the serine protease thermitase. Synthesis of an inhibitor of predicted greater potency.
Brandt W; Lehmann T; Willkomm C; Fittkau S; Barth A
Int J Pept Protein Res; 1995 Jul; 46(1):73-8. PubMed ID: 7558600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
